{
    "clinical_study": {
        "@rank": "156243", 
        "arm_group": [
            {
                "arm_group_label": "Soccer Training", 
                "arm_group_type": "Active Comparator", 
                "description": "12 weeks of soccer training. (2 times per week for the first 8 weeks and 3 times per week in the last 4 weeks. Training will consist of 15 minutes warm-up and 2 x 15 minutes matches for the first 4 weeks and of 15 minutes warm-up and 3 x 15 minutes matches for the last 8 weeks). After 12 weeks assessments participants in the intervention group will continue bi-weekly supervised training for additional 20 weeks at the end of which tests will be repeated."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Usual care"
            }
        ], 
        "brief_summary": {
            "textblock": "Androgen Deprivation Therapy (ADT) is standard treatment for locally advanced or advanced\n      Prostate Cancer (PC).\n\n      The musculoskeletal toxicity associated with ADT is well established, leading to a decrease\n      in muscle mass, increased fat percentage, weight gain, sexual dysfunction and increased risk\n      of depression, fatigue, diabetes, cardiovascular disease and reduced quality of life.\n\n      Numerous studies have shown an association between physical activity, physical capacity and\n      quality of life in cancer patients and recent epidemiological research suggest that regular,\n      moderate-intensity physical activity may have a positive effect on survival in men with\n      prostate cancer.\n\n      Within exercise physiology there is new evidence pointing to recreational soccer as a unique\n      form of intermittent exercise that effectively stimulates aerobic and anaerobic energy\n      delivery systems, leading to beneficial musculoskeletal, metabolic and cardiovascular\n      adaptations of importance for health.\n\n      It is our overall hypothesis that 12 weeks of recreational soccer training 2-3 times per\n      week will improve the health profile of PC patients receiving ADT treatment."
        }, 
        "brief_title": "Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "condition": [
            "Prostatic Neoplasms", 
            "Exercise", 
            "Soccer Training", 
            "Androgen Deprivation Therapy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Prostatic Neoplasms"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        - Patients with locally advanced or advanced prostate cancer being treated with androgen\n        deprivation therapy (S-testosterone < 1.7) for at least 6 months at the time of inclusion\n\n        Exclusion Criteria:\n\n          -  WHO performance level above 1,symptomatic cardiovascular disorders, osteoporosis\n             (T-score below -2.5)"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "57", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01711892", 
            "org_study_id": "CIRE-04"
        }, 
        "intervention": {
            "arm_group_label": "Soccer Training", 
            "intervention_name": "Soccer training", 
            "intervention_type": "Behavioral"
        }, 
        "intervention_browse": {
            "mesh_term": "Androgens"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Prostatic Neoplasms", 
            "Prostate Cancer", 
            "Exercise", 
            "Soccer", 
            "Androgen Deprivation Therapy", 
            "Body Composition", 
            "Cardiovascular fitness", 
            "Bone Health", 
            "Health Related Quality of Life"
        ], 
        "lastchanged_date": "April 16, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Copenhagen", 
                    "country": "Denmark", 
                    "zip": "2100"
                }, 
                "name": "University of Copenhagen, Centre of Integrated Rehabilitation of Cancer Patients"
            }
        }, 
        "location_countries": {
            "country": "Denmark"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Randomized Controlled Clinical Trial on the Effects of Recreational Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: The FC Prostate Study", 
        "overall_official": {
            "affiliation": "University of Copenhagen", 
            "last_name": "Mikael R\u00f8rth, Professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Denmark: National Board of Health", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Changes in body composition assessed by Dual-energy X-ray absorptiometry(DXA)scan", 
            "measure": "Baseline to post intervention (12 weeks) and follow-up (32 weeks) change in Body Composition.", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01711892"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Copenhagen", 
            "investigator_full_name": "Jacob Uth", 
            "investigator_title": "Project manager, Ph.d student, Master of Health Science", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Bone Mineral Density", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Change in maximal oxygen consumption (Vo2 peak) assessed directly during an incremental test on a cycle ergometer from baseline to post-intervention (12 weeks) and follow-up (32 weeks).", 
                "measure": "Cardiorespiratory fitness (Vo2 peak)", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Changes in Psychological distress (Hospital Anxiety and Depression Scale, HADS), Quality of Life (EORTC QLQ C-30), general well-being (SF-36), disease specific symptoms and side-effects (EORTC PR-25)from baseline to post-intervention (12 weeks) and follow-up (32 weeks)", 
                "measure": "Patient reported outcomes", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Changes in Heart function measured by Echocardiography from baseline to post-intervention (12 weeks) and follow-up (32 weeks)", 
                "measure": "Heart function", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Oral Glucose Tolerance Test", 
                "measure": "Glucose tolerance", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Assessed standing on a force platform with feet in bilateral, unilateral and tandem position. Additionally assessed with a modified Flamingo balance test.", 
                "measure": "Postural Balance", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Physical function will be assessed with sit to stand test (30s), stair climbing test and Counter Movement Jump (jump height)", 
                "measure": "Physical function", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Hip and waist circumference will be measured and the hip to waist ratio will be calculated", 
                "measure": "Hip to waist ratio", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Muscle strength will be assessed with the 1Repetition Maximum test for knee extensors", 
                "measure": "Muscle Strength", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }, 
            {
                "description": "Markers of inflammation and bone metabolism will be obtained after overnight fasting", 
                "measure": "Blood markers", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)"
            }
        ], 
        "source": "University of Copenhagen", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Danish Cancer Society", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Novo Nordisk A/S", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "TrygFonden, Denmark", 
                    "agency_class": "Industry"
                }, 
                {
                    "agency": "Beckett Foundation", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Copenhagen", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}